Degradation of Bidentate-Coordinated Platinum(II)-Based DNA Intercalators by Reduced l-Glutathione
- 16 April 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (9) , 2787-2794
Abstract
We have examined the interaction of [(5,6-dimethyl-1,10-phenanthroline)(1S,2S-diaminocyclohexane)platinum(II)]2+ (1, 56MESS), [(5-methyl-1,10-phenanthroline)(1S,2S-diaminocyclohexane)platinum(II)]2+ (2, 5MESS), [(5,6-dimethyl-1,10-phenanthroline)(1R,2R-diaminocyclohexane)platinum(II)]2+ (3, 56MERR), and [(5,6-dimethyl-1,10-phenanthroline)(ethylenediamine)platinum(II)]2+ (4, 56MEEN) with reduced l-glutathione and l-methionine. Both thiols degrade all four complexes, mainly by displacing the ancillary ligand and forming a doubly bridged dinuclear complex. The degradation half-life of all the complexes with methionine is >7 days, indicating that these reactions are not biologically relevant. The rate of degradation by glutathione appears to be particularly important and shows an inverse correlation to cytotoxicity. The least active complex, 4 (t1/2 glutathione: 20 h), degrades fastest, followed by 3 (31 h), 2 (40 h), and 1 (68 h). The major degradation product, [bis-μ-{reduced l-glutathione}bis{5,6-dimethyl-1,10-phenanthroline}bis{platinum(II)}]2+ (5, 56MEGL), displays no cytotoxicity and is excluded as the source of the anticancer activity. Once bound by glutathione, these metal complexes do not then form coordinate bonds with guanosine. Partial encapsulation of the complexes within cucurbit[n]urils is able to stop the degradation process.Keywords
This publication has 32 references indexed in Scilit:
- Novel platinum(ii)-based anticancer complexes and molecular hosts as their drug delivery vehiclesDalton Transactions, 2007
- The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalatorsJournal of Inorganic Biochemistry, 2007
- DNA Intercalators in Cancer Therapy: Organic and Inorganic Drugs and Their Spectroscopic Tools of AnalysisMini-Reviews in Medicinal Chemistry, 2007
- Direct Cellular Responses to Platinum-Induced DNA DamageChemical Reviews, 2007
- Chiral Platinum(II) Metallointercalators with Potent in vitro Cytotoxic ActivityChemMedChem, 2007
- Synthesis, Characterisation and Biological Activity of Chiral Platinum(II) ComplexesEuropean Journal of Inorganic Chemistry, 2006
- Multi-Nuclear Platinum Drugs: A New Paradigm in ChemotherapyCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- DNA binding and biological activity of some platinum(ii) intercalating compounds containing methyl-substituted 1,10-phenanthrolinesElectronic supplementary information (ESI) available: Binding data determined for platinum complexes bound to calf thymus DNA, linear dicroism spectra, Absorption spectra of the DNA alone and of the platinum complexes with DNA and solubilities of complexes in water. See http://www.rsc.org/suppdata/dt/b3/b316511f/Dalton Transactions, 2004
- Extra‐cellular thiol metabolism in clones of human metastatic melanoma with different gamma‐glutamyl transpeptidase expression: Implications for cell response to platinum‐based drugsInternational Journal of Cancer, 2002
- The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urineCancer Chemotherapy and Pharmacology, 1996